Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Huayang Liu, Meiling Piao, Jingru Zheng
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Acute respiratory distress syndrome
10.1038/s41572-019-0069-0 · 2019
Sinomenine protects against E.coli-induced acute lung injury in mice through Nrf2-NF-κb pathway
10.1016/j.biopha.2018.08.048 · 2018
The lipid biology of sepsis
10.1016/j.jlr.2021.100090 · 2021
Role of oxylipins in cardiovascular diseases
10.1038/aps.2018.24 · 2018
Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
10.1007/s11306-022-01898-4 · 2022
Lipidomic profiling of bronchoalveolar lavage fluid extracellular vesicles indicates their involvement in lipopolysaccharide-induced acute lung injury
10.1159/000522338 · 2022
Recent advances in lipidomics: analytical and clinical perspectives
10.1016/j.prostaglandins.2016.12.002 · 2017
Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics
10.1016/j.jchromb.2021.123069 · 2022
Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis
10.1007/s00011-015-0897-7 · 2016
Lipidomics study of sepsis-induced liver and lung injury under anti-HMGB1 intervention
10.1021/acs.jproteome.2c00851 · 2023
The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
2020
VNS-mediated α7nAChR signaling promotes SPM synthesis via regulation of netrin-1 expression during LPS-induced ALI
2024
Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway
10.1016/j.redox.2021.101954 · 2021
UHPLC-MS/MS-based untargeted lipidomics analysis of septic patients
10.1016/j.cca.2023.117336 · 2023
Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives
10.1007/s00441-014-1821-0 · 2014
The cytokine storm of severe influenza and development of immunomodulatory therapy
10.1038/cmi.2015.74 · 2016
Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids
2022
Author correction: link between serum lipid signature and prognostic factors in COVID-19 patients
10.1038/s41598-022-07501-z · 2022
Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19
10.1002/ctm2.1069 · 2022
Role of lipids in killing mycobacteria by macrophages: evidence for NF-kappaB-dependent and -independent killing induced by different lipids
10.1111/j.1462-5822.2008.01263.x · 2009
The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes
10.1080/10408369891234246 · 1998
Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients
10.1194/jlr.p023309 · 2012
Pulmonary surfactant in health and human lung diseases: state of the art
10.1183/09031936.99.13614779 · 1999
Phospholipid regulation of innate immunity and respiratory viral infection
10.1074/jbc.aw118.003229 · 2019
Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study
10.1152/ajplung.00128.2017 · 2018
Comprehensive lipid profiling of bleomycin-induced lung injury
10.1002/jat.3758 · 2019
Eicosanoids, β-cell function, and diabetes
10.1016/j.prostaglandins.2011.06.001 · 2011
Resolvins and protectins in inflammation resolution
10.1021/cr100396c · 2011
Role of basic science in the development of new medicines: examples from the eicosanoid field
10.1074/jbc.x112.351437 · 2012
Resolution of acute inflammation in the lung
10.1146/annurev-physiol-021113-170408 · 2014
Pro-resolving lipid mediators are leads for resolution physiology
10.1038/nature13479 · 2014
Lipoxin A4 alleviates lung injury in sepsis rats through p38/MAPK signaling pathway
2020
Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway
10.1016/j.intimp.2019.05.046 · 2019
Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κb and PI3K/Akt signaling pathway in mice
2017
Annexin A1 mimetic peptide AC2-26 inhibits sepsis-induced cardiomyocyte apoptosis through LXA4/PI3K/AKT signaling pathway
10.1007/s11596-018-1975-1 · 2018
CYP450-derived oxylipins mediate inflammatory resolution
10.1073/pnas.1521453113 · 2016
Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages
2014
An integrated clinico-metabolomic model improves prediction of death in sepsis
10.1126/scitranslmed.3005893 · 2013
Metabolomic derangements are associated with mortality in critically ill adult patients
10.1371/journal.pone.0087538 · 2014
A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis
10.1165/rcmb.2014-0343oc · 2015
Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction
10.1002/jcp.24939 · doi-reference
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis
10.2353/ajpath.2010.091082 · doi-reference